Hadassah’s innovation engine
From the lab to life-saving technologies
Hadasit is the growth engine for health innovation originating
from the Hadassah University Medical Center’s ecosystem.
from the Hadassah University Medical Center’s ecosystem.
Transforming ideas
into breakthroughs
in healthcare
Uniquely placed to nurture ideas inspired in clinical practice, we work side by side with physicians to identify unmet medical needs, aligning inventions with market and regulatory expectations, and raising capital to support proof-of-concept R&D.
Aligned with industry
We understand what it takes to advance innovation toward commercialization. As a bridge between industry, academia, and clinicians on the frontlines, we execute flexible business and revenue models that promote and support a variety of deals. This includes spinning off independent companies, licensing technologies, and collaborating with leading international companies and research facilities.
To date, Hadasit had spun off over 50 companies,
including the publicly traded Hadasit Bio-Holdings
(TASE: HDST) in which Hadasit is a major shareholder.
To date, Hadasit had spun off over 50 companies,
including the publicly traded Hadasit Bio-Holdings
(TASE: HDST) in which Hadasit is a major shareholder.
Our Team
Dr. Tamar Raz has nearly two decades of experience in technology transfer and an impressive track record of bringing medical innovations from the lab to the marketplace. Prior to joining Hadasit, she served as VP of Marketing and Strategy at Ramot, the technology transfer company of Tel Aviv University. Tamar was the founder and CEO of Allergene Ltd, an Israeli drug development start-up company. She received her MSc and PhD in cell biology from the Tel Aviv University School of Medicine.
Carole Grumbach promotes Hadassah R&D services to domestic and international markets. She first joined Hadasit in 1990 as its finance manager. Today, she is responsible for the global financial management of Hadasit, specializing in contractual and budgetary aspects of negotiations with commercial partners. Carole received her MBA in economics and management from the University Paris IX-Dauphine.
Tamir Levital brings close to 20 years of healthcare and cleantech management and business development experience, including over a decade as a CEO of a medical device start-up. His experience spans across healthcare and cleantech business development, fundraising (including angel investments, strategic partnerships, sponsored research and government grants), academic technology licensing, developing commercial strategies, managing R&D, clinical trials, medical regulation, legal aspects and patents. Tamir holds an M.Sc. in Animal Science from McGill University, Montreal, Canada; and a B.Sc. in Biology from the Hebrew University, Jerusalem.
Dr. Nadav Askari leads Hadasit’s pharmaceuticals, life sciences, biotech and molecular diagnostics portfolio. For over a decade, Nadav held various leadership positions in the life science industry. Prior to joining Hadasit, he served as the CTO of Genetika+ Ltd., a precision medicine biotech startup. From 2012-2021 he headed the proteins and kits R&D in Merck KGaA, where he directed the development and launching of dozens of products. Nadav also served as an advisor to tech transfer and innovation teams at the Weizmann Institute. Dr. Askari obtained his M.Sc. (cum laude) and Ph.D. in biochemistry and cell biology from the Hebrew University of Jerusalem, and performed a postdoctoral training in Sanford-Burnham-Prebys Medical Discovery Institute (La Jolla, CA, USA).
Dr. Adriana Folberg-Blum has over 20 years of hands-on experience in the practice of intellectual property, including developing, maintaining and managing IP portfolios, primarily in the biotech industry, both as in-house counsel and in private practice. Before joining Hadasit, she served as the IP Manager at the Tel Hashomer Hospital Technology Transfer Company. Adriana received her PhD from McGill University in Canada and completed her post-doctoral work at the Weizmann Institute.
Masha Zavin has more than a decade of experience in project management, business development, marketing and sales in diverse industries. Before joining Hadasit in 2021, she was the Sales and Marketing Manager at iMER Ltd., the international marketing arm of Hadassah Medical Center. Masha received her LL.B in private international law from the State University Higher School of Economics, Moscow and graduated from the Hebrew University MBA Biomed program.
Adv. Aviv Reisfeld drafts and negotiates the terms and conditions of various types of agreements and offers counsel on all aspects of life science commercialization activities and intellectual property issues. He joined Hadasit more than a decade ago. Aviv is a member of the Israel Bar Association and received his MBA from Bar-Ilan University and an LLB from Warwick University.
Sarah Kimhi joined Hadasit more than two decades ago. Prior to that, she was the secretary to the Deputy Minister of Foreign Affairs. Sarah received her BA from the Hebrew University of Jerusalem.
Board of Directors
Prof. Yoram Weiss
Director General of the Hadassah Medical Organisation
Mrs. Dalia Itzik
Chairperson, Hadasit Ltd.
Chairperson, Hadassah Medical Organization
Chairperson, Hadassah Medical Organization
Mr. Yigal Molad Hayo
Director , Hadassah Medical Organization
Chair of the Finance committee , Hadassah Medical Organization
Chair of Hadassah Medical
Director, Hadasit Ltd.
Chair of the Finance committee , Hadassah Medical Organization
Chair of Hadassah Medical
Director, Hadasit Ltd.
Prof. Eyal Mishani
Head, Research and Development Division
Head, Cyclotron/ Radiochemistry Unit
General Director, Research Fund of the
Hadassah Medical Organization
Head, Cyclotron/ Radiochemistry Unit
General Director, Research Fund of the
Hadassah Medical Organization
Mr. Yuval Adar
Chief Financial Officer, Hadassah Medical Organization
Prof. Asher Elhayany MD, MPA
Professor, Dept. of Health Management, Ariel University.
Director , Dept. of Family Medicine, Assia Health Services
Director , Dept. of Family Medicine, Assia Health Services
Prof. Chezy Ofir
Chair Professor Emeritus
Mr. Eitan Padan
Director
Dr. David Zacut
Director
Dr. Yifat Ben Hay-Segev
Director
Mr. Aviv Bushinsky
Director